Technical Analysis and Multiplex Detection Advantages of the Ureaplasma urealyticum/Chlamydia trachomatis/Neisseria gonorrhoeae/Mycoplasma genitalium Nucleic Acid Detection Kit (Fluorescence PCR Method)

Technical Architecture of Fluorescent PCR in a Quadruplex Assay

The Ureaplasma urealyticum/Chlamydia trachomatis/Neisseria gonorrhoeae/Mycoplasma genitalium Nucleic Acid Detection Kit (Fluorescent PCR Method) employs real-time fluorescent polymerase chain reaction technology. By designing specific primers and TaqMan probes targeting conserved gene regions of the four pathogens, it achieves simultaneous amplification and detection of multiple targets in a single reaction tube. Common design strategies include: selecting the ureC gene for Ureaplasma urealyticum, the cryptic plasmid or ompA gene for Chlamydia trachomatis, the porA or opa gene for Neisseria gonorrhoeae, and the MgPa or gap gene for Mycoplasma genitalium. Different fluorescent channels (e.g., FAM, HEX, ROX, Cy5) are used to distinguish each target, and an endogenous internal control (e.g., RNase P gene) is incorporated to monitor sample quality and amplification inhibition. The kit typically includes a UNG enzyme anti-contamination system, which can degrade residual PCR products before amplification to reduce the risk of false positives.

Sensitivity and Specificity Performance of Multiplex Detection

Compared with single-target detection kits, the quadruplex assay significantly reduces sample consumption and turnaround time while maintaining high sensitivity. Multiple studies have shown that under the same extraction conditions, the lower limit of detection for quadruplex fluorescent PCR can reach common specifications such as 10³ copies/mL or lower, with a concordance rate typically above 95% compared with single-target detection (data from published literature). Regarding specificity, primer design must avoid regions with high homology to the human genome and common commensal microorganisms (such as Lactobacillus and Gardnerella), and must be verified through BLAST alignment. Notably, there is a potential risk of cross-reactivity between Neisseria gonorrhoeae and Neisseria meningitidis, Moraxella catarrhalis, and others; therefore, kits often incorporate competitive probes or melting curve analysis to differentiate them. During clinical validation, a sufficient number of negative samples must be included to assess the false-positive rate, generally requiring specificity of no less than 98%.

Key Control Points in Clinical Use

Sample collection and transport are important prerequisites for the detection accuracy of this kit. Dedicated cervical swabs, urethral swabs, or urine samples (first-void morning urine or midstream urine after at least 2 hours of urine retention) are usually recommended. After collection, samples should be immediately placed in transport medium containing preservatives or in normal saline, and stored at 2–8°C for no more than 48 hours. For long-term storage, samples should be frozen at -20°C or lower, avoiding repeated freeze-thaw cycles. PCR inhibitors in samples (such as hemoglobin, mucus, and urate) may affect amplification efficiency; therefore, efficient magnetic bead-based or column purification methods should be used in the extraction step, with strict monitoring of internal control signals. For the amplification process, it is recommended to use a compatible real-time PCR instrument and set thermal cycling parameters according to the kit instructions (e.g., pre-denaturation at 95°C for 5 min, 40 cycles of 95°C for 15 s and 60°C for 60 s). Instrument calibration should be performed regularly to avoid misinterpretation caused by channel crosstalk.

Considerations for Kit Transport and Storage Stability

According to general industry requirements, kits packaged with desiccant can be stored at -20°C for 12–18 months in a sealed state, but repeated freeze-thaw cycles may reduce enzyme activity; therefore, aliquoting before use is recommended. Dry ice cold chain should be used during transport to ensure the temperature remains below -15°C throughout. For opened reagents, some components such as the enzyme mixture need to be used immediately or stored short-term at 2–8°C. Users should record the reagent lot number and expiration date, and avoid using expired products. In the result interpretation step, the valid amplification curve shape and Ct value threshold set by the kit (usually recommended to be set between 35 and 38) should be followed. If the internal control is not detected and there is no target signal, the result should be judged as invalid and retested. Overall, rational technical design and rigorous operational procedures are the foundation for ensuring the performance of the quadruplex detection kit.